ASRS 2023: Fernando Arevalo on retinal detachments associated to retinoschisis

News
Video

Fernando Arevalo, MD, PhD, FACS, FASRS, shared information on his presentation on the treatment of progressively symptomatic retinal detachments associated to retinoschisis cases at the 2023 ASRS annual meeting.

Fernando Arevalo, MD, PhD, FACS, FASRS, shared information on his ASRS 2023 presentation, which focussed on the treatment of progressively symptomatic retinal detachments associated to retinoschisis cases. Arevalo is a member of the Modern Retina board.

Video Transcript

Editor's note - This transcript has been edited for clarity.

Fernando Arevalo, MD, PhD, FACS, FASRS:

Hello, my name is Fernando Arevalo, and I'm a professor of ophthalmology at Johns Hopkins University and Wilmer Eye Institute in Baltimore, Maryland. I'm here in Seattle at the American Society of Retinal Specialists, and 1 of the things that I am presenting is the treatment of progressively symptomatic retinal detachments associated to retinoschisis cases.

I presented on a patient that had, or was treated with, phaco-vitrectomy and retinectomy to repair one of those complex detachments. We performed a complete vitrectomy with peripheral vitrectomy as well, the use of perfluorocarbon to flood in the retina, and that was to some traction in the periphery with the phaco to allow us to do more peripheral shaving. And even with that there was still some traction and elevation in the periphery.


In addition, the patient had already a 41 band [in] place, and with this traction still in the periphery, I decided to perform a retinectomy. Basically the roofing of the inner retina to allow the area of the retina peripherally to flatten, and that allowed the retina to reattach when the laser was applied, perfluorocarbon was injected, and then an [inaudible] change and then silicone oil because it was a monocular patient, but gas can also be used.

This technique comes from a study that we published recently on 18 cases with progressively symptomatic retinal detachment associated retinas cases where we usually, most of the cases combination of a buckle and vitrectomy. And we found that, in a follow up of about 4 years, there were a third of patients that had a failure with 1 surgery. Although their final success rate was 100%, I think that the fact that the 1 surgery success rate was only 66% emphasises how difficult it is to repair, these retinal detachments. And more research is needed to evaluate what are the best surgical techniques to repair these kinds of retinal detachments.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
Related Content
© 2025 MJH Life Sciences

All rights reserved.